NAN Stock Overview
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
NAN passed our risk checks.
Nanosonics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$2.91 |
| 52 Week High | AU$5.63 |
| 52 Week Low | AU$2.59 |
| Beta | 1.57 |
| 1 Month Change | 2.83% |
| 3 Month Change | -1.02% |
| 1 Year Change | -48.04% |
| 3 Year Change | -43.50% |
| 5 Year Change | -39.38% |
| Change since IPO | 254.88% |
Recent News & Updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27
Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Is Nanosonics' (ASX:NAN) Share Price Gain Of 250% Well Earned?
Jul 28Shareholder Returns
| NAN | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 6.2% | 2.1% | 1.8% |
| 1Y | -48.0% | 17.4% | 7.0% |
Return vs Industry: NAN underperformed the Australian Medical Equipment industry which returned 17.4% over the past year.
Return vs Market: NAN underperformed the Australian Market which returned 7% over the past year.
Price Volatility
| NAN volatility | |
|---|---|
| NAN Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 10.1% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: NAN has not had significant price volatility in the past 3 months.
Volatility Over Time: NAN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 482 | Michael Kavanagh | www.nanosonics.com.au |
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform.
Nanosonics Limited Fundamentals Summary
| NAN fundamental statistics | |
|---|---|
| Market cap | AU$887.73m |
| Earnings (TTM) | AU$15.68m |
| Revenue (TTM) | AU$164.07m |
56.2x
P/E Ratio5.4x
P/S RatioIs NAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAN income statement (TTM) | |
|---|---|
| Revenue | AU$164.07m |
| Cost of Revenue | AU$34.34m |
| Gross Profit | AU$129.73m |
| Other Expenses | AU$114.04m |
| Earnings | AU$15.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.052 |
| Gross Margin | 79.07% |
| Net Profit Margin | 9.56% |
| Debt/Equity Ratio | 0% |
How did NAN perform over the long term?
See historical performance and comparison